Jobs

Vir Biotechnology

VI

Vir Biotechnology

Immunology-focused biotech

Drug Discovery

Immunology

Infectious Diseases

Clinical Research

Bioinformatics

San Francisco, California

201-500

Founded in 2016 (10 years ago)

Hybrid

Public

Valuation

$1.2B

Total funding

$700M

VIR

$9.78

Open roles at Vir Biotechnology

3 open roles

Senior Manager, Quality Control

Engineering

San Francisco, California, United States

On-site

Senior

Full-time

Learning Budget

401(k)

Performance Bonus

Commuter Benefits

Senior Director, Clinical Research-Infectious Disease

Machine Learning

San Francisco, California, United States

On-site

Director

Full-time

Learning Budget

401(k)

Performance Bonus

Commuter Benefits

Associate Director, Clinical Transactional Counsel

Healthcare

San Francisco, California, United States

On-site

Director

Full-time

Learning Budget

401(k)

Performance Bonus

Commuter Benefits

Closed positions

50 positions

Scientist, In Vivo (Temporary)

San Francisco, California, United States

Mid Level

Closed 3d ago

Principal Regulatory Writer (Temporary)

Remote - United States

Staff

Closed 4d ago

Regulatory Writer and/or Regulatory QC/ Editor (Temporary)

Remote - United States

Mid Level

Closed 5d ago

Senior Regulatory Writer (Temporary)

Remote - United States

Senior

Closed 6d ago

Senior Director, Clinical Research-Oncology

San Francisco, California, United States

Director

Closed 1 week ago

Products and services

Tobevibart and Elebsiran Combination Therapy for Chronic Hepatitis Delta

Tobevibart and Elebsiran Combination Therapy for Chronic Hepatitis Delta

Antiviral Therapeutics

VI

VIR-2218

Antiviral Therapy

VI

VIR-3434

Monoclonal Antibody

VI

VIR-7831 (Sotrovimab)

Monoclonal Antibody

EL

Elebsiran (VIR-2218)

Antiviral Therapy

PRO-XTEN™ Masked T-cell Engagers for Oncology

PRO-XTEN™ Masked T-cell Engagers for Oncology

Immuno-Oncology

PL

Platform Technologies

Technology Platform

CO

COVID-19 Variant Antibodies

Monoclonal Antibody

SO

Sotrovimab

Antiviral Therapy

HI

HIV Cure Research

Antiviral Therapy

VI

VIR-7229

Antiviral Therapy

MA

Malaria Prevention Program

Monoclonal Antibody

VI

VIR-2482

Antiviral Therapy

VI

VIR-1111

T Cell Immunotherapy

TO

Tobevibart (VIR-3733)

Antiviral Therapy

T

T Cell Platform

Platform Technology

CO

COVID-19 Antibody Program

Antiviral Therapy

Leadership

LP

Louis Picker

Co-Founder

KF

Klaus Frueh

Co-Founder

RN

Robert Nelsen

Co-Founder

SR

Steven Rice

Chief Administrative Officer

Total Views

91

Total Apply Clicks

0

Total Mock Apply

0

Total Bookmarks

0

Reviews

3.7

10 reviews

Work-life balance

3.2

Compensation

2.8

Culture

4.1

Career

3.8

Management

3.0

65%

Recommend to a friend

Pros

Supportive and collaborative team culture

Cutting-edge research and meaningful work

Professional development opportunities

Cons

Heavy workload and frequent overtime

Management lacks clear direction and communication

Fast-paced and high-pressure environment

Salary Ranges

22 data points

Junior/L3

1 reports

-

total per year

Base

$135,000

Stock

-

Contact and location